BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1265555)

  • 1. Clinical aspects of monocomponent insulins in the treatment of diabetes.
    Vinik AI; Joffe BI; Seftel HC; Distiller LA; Jackson WP
    S Afr Med J; 1976 Apr; 50(15):587-91. PubMed ID: 1265555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating antibodies in diabetics treated with conventional and purified insulins.
    Klaff LJ; Vinik AI; Berelowitz M; Jackson WP
    S Afr Med J; 1978 Jul; 54(4):149-53. PubMed ID: 694712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
    Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
    Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenicity of "monocomponent" pork insulin in diabetic subjects.
    Yue DK; Turtle JR
    Diabetes; 1975 Jul; 24(7):625-32. PubMed ID: 1171804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin.
    Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K
    Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monocomponent insulins (author's transl)].
    Rodriguez-Miñón JL
    MMW Munch Med Wochenschr; 1977 Sep; 119(38):1215-20. PubMed ID: 409943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of insulin lipoatrophy with monocomponent insulin.
    Teuscher A
    Diabetologia; 1974 Jun; 10(3):211-4. PubMed ID: 4845721
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlled study comparing treatment with monocomponent insulin and conventional insulin in patients with lipoatrophy.
    Czyzyk A; Rogala H; Lawecki J
    Acta Diabetol Lat; 1989; 26(1):17-26. PubMed ID: 2665407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment.
    Bruni B; Gamba S; Regis G; Turco GL
    Diabetologia; 1978 Mar; 14(3):165-9. PubMed ID: 566232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical trial with porcine monocomponent lente insulin (Monotard).
    Bruni B; Bruni Bocher K; Gamba S; Giolitti A; Rittatore R; Turco GL
    Panminerva Med; 1977; 19(4):247-54. PubMed ID: 593701
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of insulin-binding antibodies in diabetic patients treated with monocomponent insulin.
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Diabetologia; 1974 Jun; 10(3):233-6. PubMed ID: 4845724
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirement and on some complications.
    Andreani D; Iavicoli M; Tamburrano G; Menzinger G; Maltarello C
    Horm Metab Res; 1974 Nov; 6(6):447-54. PubMed ID: 4476720
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum levels of insulin-binding antibodies treated with monocomponent insulin].
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Pol Tyg Lek; 1974 Feb; 29(8):301-4. PubMed ID: 4856084
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin allergy: reaginic antibodies to insulin and proinsulin.
    Kumar D; Rosenquist RJ; Parameswaran V
    J Clin Endocrinol Metab; 1979 Aug; 49(2):252-4. PubMed ID: 457844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of insulin antibodies after monocomponent insulin therapy].
    Takemura Y; Kase T; Hiraiwa M; Hashigami Y; Imai N
    Horumon To Rinsho; 1982 Oct; 30(10):1109-12. PubMed ID: 7165985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.